Seeking Alpha

Baxter (BAX) will acquire privately-held Prism Pharma for $338M, $168M of that based on...

Baxter (BAX) will acquire privately-held Prism Pharma for $338M, $168M of that based on milestones. Prism's NEXTERONE portfolio includes the only ready-to-use premixed IV bag formulations, as well as vials and a pre-filled syringe. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|